Acarbose improves glycemic control as add-on or monotherapy in Indian type-2 diabetes: Findings from the GlucoVIP multinational observational study
Objective: To investigate the efficacy and tolerability of the anti-diabetic agent acarbose (Glucobay® ) as add-on or monotherapy in a range of patients with type-2 diabetes mellitus (T2DM), including those with cardiovascular morbidities in India. Materials and Methods: This was a part of a prospec...
| Hlavní autoři: | , , , , , , , |
|---|---|
| Médium: | Článek |
| Jazyk: | English |
| Vydáno: |
Wolters Kluwer Medknow Publications
2013-01-01
|
| Edice: | Indian Journal of Endocrinology and Metabolism |
| Témata: | |
| On-line přístup: | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=9;spage=674;epage=679;aulast=Philip |